ES8400076A1 - Procedimiento para hidroformilar compuestos olefinicamente insaturados. - Google Patents

Procedimiento para hidroformilar compuestos olefinicamente insaturados.

Info

Publication number
ES8400076A1
ES8400076A1 ES507810A ES507810A ES8400076A1 ES 8400076 A1 ES8400076 A1 ES 8400076A1 ES 507810 A ES507810 A ES 507810A ES 507810 A ES507810 A ES 507810A ES 8400076 A1 ES8400076 A1 ES 8400076A1
Authority
ES
Spain
Prior art keywords
preparation
pharmaceutical preparations
cytosine derivatives
tricyclic cytosine
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES507810A
Other languages
English (en)
Other versions
ES507810A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of ES8400076A1 publication Critical patent/ES8400076A1/es
Publication of ES507810A0 publication Critical patent/ES507810A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/24—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Fats And Perfumes (AREA)
  • Lubricants (AREA)

Abstract

PROCEDIMIENTO PARA INDUCIR LA HIDROFORMILACION DE COMPUESTOS OLEFINICAMENTE INSATURADOS.SE EFECTUA UNA HIDROFORMILACION PREVIA CON TRIFENILFOSFINA Y ACETATO DE RODIO BAJO CALENTAMIENTO A UNA PRESION DE CO/H2 DE 5-20 BAR A 90-120JC, ELIMINANDO DEL REACTOR EL ACIDO ACETICO LIBRADO EN FORMA GASEOSA EN UNA CORRIENTE DE CO/H2 DURANTE UN TIEMPO SUFICIENTE PARA QUE NO PUEDA IDENTIFICARSE PRACTICAMENTE NINGUN ACIDO ACETICO EN LA DESCARGA DE GAS. EL TIEMPO EMPLEADO OSCILA ENTRE 2 Y 8 HORAS. LOS ALDEHIDOS FORMADOS COMO PRODUCTOS DEL PROCESO, ASI COMO LOS ALCOHOLES PUEDENSER ELIMINADOS DEL REACTOR DE MODO CONVENCIONAL EN FORMA DE GAS CONJUNTAMENTE CON EL CO, H2 Y LA OLEFINA SIN REACCIONAR.
ES507810A 1980-12-09 1981-12-09 Procedimiento para hidroformilar compuestos olefinicamente insaturados. Granted ES507810A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803046366 DE3046366A1 (de) 1980-12-09 1980-12-09 Tricyclische cytosinderivate zur verwendung in arzneimitteln und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
ES8400076A1 true ES8400076A1 (es) 1983-10-16
ES507810A0 ES507810A0 (es) 1983-10-16

Family

ID=6118700

Family Applications (2)

Application Number Title Priority Date Filing Date
ES507810A Granted ES507810A0 (es) 1980-12-09 1981-12-09 Procedimiento para hidroformilar compuestos olefinicamente insaturados.
ES507807A Expired ES8300111A1 (es) 1980-12-09 1981-12-09 Procedimiento para la obtencion de derivados triciclicos de citosina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES507807A Expired ES8300111A1 (es) 1980-12-09 1981-12-09 Procedimiento para la obtencion de derivados triciclicos de citosina.

Country Status (13)

Country Link
US (1) US4585772A (es)
EP (1) EP0053767B1 (es)
JP (1) JPS57122085A (es)
AT (1) ATE9350T1 (es)
AU (1) AU549240B2 (es)
CA (1) CA1184910A (es)
DE (2) DE3046366A1 (es)
DK (1) DK542781A (es)
ES (2) ES507810A0 (es)
FI (1) FI813912L (es)
HU (1) HU191038B (es)
IL (1) IL64472A0 (es)
ZA (1) ZA818499B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713383A (en) * 1984-10-01 1987-12-15 Ciba-Geigy Corporation Triazoloquinazoline compounds, and their methods of preparation, pharmaceutical compositions, and uses
US4831013A (en) * 1986-03-20 1989-05-16 Ciba-Geigy Corporation 2-substituted-e-fused-[1,2,4]triazolo[1,5-c]pyrimidines, pharmaceutical compositions, and uses thereof
FR2659329B1 (fr) * 1990-03-09 1994-06-03 Adir Nouveaux derives d'imidazo [1,2-c] quinazoline, leur procede de preparation et les compositions pharmaceutiques les renfermant.
US5158953A (en) * 1991-08-13 1992-10-27 National Science Council 2-substituted methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-ones (thiones), the preparation and use thereof
US5212310A (en) * 1991-12-19 1993-05-18 Neurogen Corporation Certain aryl fused imidazopyrimidines; a new class of GABA brain receptor ligands
US5539260A (en) * 1994-08-29 1996-07-23 Ford Motor Company Method and apparatus for an automotive security system which permits engine running prior to code comparison
US5637929A (en) * 1996-01-16 1997-06-10 Ford Motor Company Method and apparatus for enhanced vehicle protection
CA2381008A1 (en) * 1999-08-04 2001-02-15 Millennium Pharmaceuticals, Inc. Melanocortin-4 receptor binding compounds and methods of use thereof
US7375125B2 (en) * 1999-08-04 2008-05-20 Ore Pharmaceuticals, Inc. Melanocortin-4 receptor binding compounds and methods of use thereof
GB2454549B (en) * 2007-09-25 2009-09-23 Medical & Pharm Ind Tech & Dev Uses of 2-[piperidinyl]methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one for providing an anti-allergic effect and histamine H1 receptor antagonism effect
US9365575B2 (en) 2012-05-21 2016-06-14 Allergan, Inc. Kinase inhibitors
RU2653054C2 (ru) 2012-06-18 2018-05-07 Дарт Нейросайенс (Кайман) Лтд Замещенные соединения пиридин азолопиримидин-5-(6н)-она
JP6420400B2 (ja) * 2017-04-12 2018-11-07 ダート・ニューロサイエンス・（ケイマン）・リミテッド 置換ピリジンアゾロピリミジン−５−（６ｈ）−オン化合物
CN108178759B (zh) * 2018-01-05 2020-06-09 上海瑞纷医药科技有限责任公司 一种α-肾上腺素受体拮抗剂的合成方法
GB2575490A (en) 2018-07-12 2020-01-15 Recordati Ind Chimica E Farmaceutica Spa P2X3 receptor antagonists
EP4389746A3 (en) * 2022-12-21 2024-07-03 Recordati Industria Chimica E Farmaceutica SPA P2x3 receptor antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3329679A (en) * 1965-12-22 1967-07-04 American Home Prod Fused-ring imidazoquinazolines, pyrimidoquinazolines and related compounds
US3594379A (en) * 1968-09-16 1971-07-20 Sandoz Ag 2,3-dihydroimidazo(1,2-c)quinazolines
CA986932A (en) * 1970-08-27 1976-04-06 Shigeho Inaba Process for preparing quinazoline derivatives
IE51802B1 (en) * 1979-12-03 1987-04-01 Fujisawa Pharmaceutical Co Quinazoline derivatives,processes for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
FI813912L (fi) 1982-06-10
AU549240B2 (en) 1986-01-23
JPS57122085A (en) 1982-07-29
ZA818499B (en) 1982-11-24
ES507810A0 (es) 1983-10-16
US4585772A (en) 1986-04-29
HU191038B (en) 1986-12-28
CA1184910A (en) 1985-04-02
EP0053767B1 (de) 1984-09-12
ES507807A0 (es) 1982-10-01
ATE9350T1 (de) 1984-09-15
IL64472A0 (en) 1982-03-31
DK542781A (da) 1982-06-10
DE3166084D1 (en) 1984-10-18
ES8300111A1 (es) 1982-10-01
DE3046366A1 (de) 1982-07-08
AU7831781A (en) 1982-06-17
EP0053767A1 (de) 1982-06-16

Similar Documents

Publication Publication Date Title
ES8402591A1 (es) Procedimiento para la obtencion de pirazolooxacinas, pirazolotiacinas y pirazoloquinolinas.
ATE22562T1 (de) 6-substituierte s-triazolo(3,4-a)phthalazinderivate.
HUT34746A (en) Process for the production of 2-pyrimidinil-1-piperazine-derivatives and of medical preparations containing them as agent
ES8300111A1 (es) Procedimiento para la obtencion de derivados triciclicos de citosina.
ES486280A1 (es) Procedimiento para la obtencion de hidroxietil-azoles
ES486279A1 (es) Procedimiento para la obtencion de hidroxipropil-triazoles
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
ES8200094A1 (es) Procedimiento para la obtencion de alquilureas
JO1406B1 (en) Chemical compounds
ES8305684A1 (es) Procedimiento para la obtencion de derivados aminopropanolicos de 2-hidroxi b-fenil-propiofenonas.
ES8301244A1 (es) Procedimiento para la obtencion de derivados de sisomicina.
DE2962580D1 (en) 7-phenyl-quinolizidine derivatives (i), their preparation, pharmaceutical compositions containing them and (i) for use in treating diseases
ES8106003A1 (es) Procedimiento para la obtencion de acido fosfonohidroxiace- tico
ES8401064A1 (es) Procedimiento para la obtencion de azolil-fenoxi-tetrahidrofuran-2-iliden-metanos.
ES8103112A1 (es) Procedimiento para la obtencion de pseudo-trisacaridos
ES8305783A1 (es) Procedimiento para la obtencion de derivados de aminociclitol saturados.
ES8802612A1 (es) Procedimiento para preparar derivados de benzisoselenazolilo
ES8304152A1 (es) Procedimiento para la obtencion de derivzados de aminociclitol.
ES480091A1 (es) Metodo de producir (omega-aminoalcoxi) bibencilos farmaceu- ticamente activos.
ES474052A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridazinas 1-n-sustituidas.
EP0004261A3 (en) Imidazole derivatives, method and intermediates for their preparation and pharmaceutical compositions containing such imidazole derivatives, as well as the use of such imidazole derivatives in combating diseases